Filing Analysis
Caleres, Inc. filed an 8-K to announce its quarterly results of operations for the period ended November 2, 2024.
📋 Key Facts
- The filing was made on December 5, 2024.
- The company reported results for the quarter ending November 2, 2024.
- Information is provided via a press release attached as Exhibit 99.1.
Caleres, Inc. announced the election of two new independent directors, Kyle F. Gendreau and Molly Langenstein, to fill existing vacancies on the Board. Additionally, the company amended its bylaws to increase the total number of director seats from eleven to twelve.
🚩 Red Flags
- None identified; this is a standard governance update.
📋 Key Facts
- Elected Kyle F. Gendreau and Molly Langenstein to the Board of Directors effective November 5, 2024.
- The new directors fill vacancies resulting from a previous departure in August 2024 and an increase in board size.
- Both new directors have been designated as 'independent' under NYSE and SEC rules.
- Bylaws were amended to increase the number of directors from eleven to twelve.
- New directors will receive compensation consistent with non-employee director standards outlined in the April 11, 2024 Proxy Statement.
Caleres, Inc. filed an 8-K to announce its quarterly results of operations for the period ended August 3, 2024. The filing serves as a formal notice that a press release containing financial performance data has been issued.
📋 Key Facts
- The company reported results for the quarter ended August 3, 2024.
- A press release was issued on September 12, 2024, as Exhibit 99.1.
- The filing is made pursuant to Item 2.02 (Results of Operations and Financial Condition).
Caleres, Inc. announced the resignation of Board member Carla C. Hendra, effective following the next scheduled Board meeting in late August 2024.
📋 Key Facts
- Carla C. Hendra resigned from the Board of Directors on July 17, 2024.
- The resignation becomes effective immediately following the next regularly scheduled Board meeting (August 28-29, 2024).
- The company explicitly stated that the resignation did not result from any disagreement regarding operations, policies, or practices.
Caleres, Inc. filed an 8-K to announce its quarterly results of operations for the period ended May 4, 2024 via a press release.
📋 Key Facts
- The filing is related to Item 2.02 (Results of Operations and Financial Condition).
- Quarterly results were announced on May 30, 2024.
- The reporting period ended on May 4, 2024.
Caleres, Inc. reported the results of its Annual Meeting of Shareholders held on May 23, 2024. The meeting included the election of 11 directors, ratification of Ernst & Young LLP as independent auditors, and approval of executive compensation.
📋 Key Facts
- Annual Meeting of Shareholders held on May 23, 2024.
- Eleven directors were elected to one-year terms: Lisa A. Flavin, Brenda C. Freeman, Lori H. Greeley, Mahendra R. Gupta, Carla C. Hendra, Ward M. Klein, Steven W. Korn, Wenda Harris Millard, John W. Schmidt, Diane M. Sullivan, and Bruce K. Thorn.
- Shareholders ratified the appointment of Ernst & Young LLP as independent registered public accountants with 29,365,197 votes in favor.
- The 'say on pay' advisory resolution regarding executive compensation was approved by shareholders.
Caleres, Inc. filed an 8-K to announce its quarterly results of operations for the period ended February 3, 2024. The filing serves as a formal notice that a press release containing these financial results has been issued.
📋 Key Facts
- The company reported results for the quarter ended February 3, 2024.
- A press release was issued on March 19, 2024, as Exhibit 99.1.
- The filing is made pursuant to Item 2.02 (Results of Operations and Financial Condition).
Caleres, Inc. issued a press release to reaffirm its previously provided financial outlook for consolidated sales, earnings per share (EPS), and adjusted EPS for the full year 2023.
📋 Key Facts
- The company reaffirmed its full-year 2023 guidance for consolidated sales, EPS, and adjusted EPS on January 8, 2024.
- Information was released via press release in accordance with Regulation FD.